Search results
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) -...
Morningstar· 4 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
Gabelli Funds LLC Has $3.80 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoGabelli Funds LLC trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the ...
UPCOMING DEADLINE ALERT: Biogen Inc. (Nasdaq: BIIB) Investors are Encouraged to Contact BFA Law...
Morningstar· 6 days agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities ...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 7 days agoGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB) Glancy Prongay & Murray LLP (“GPM”) reminds investors ...
RBC maintains Biogen Outperform stock rating, awaits Leqembi sales acceleration By Investing.com
Investing.com· 6 days agoOn Wednesday, RBC Capital expressed continued confidence in Biogen (NASDAQ:BIIB), maintaining an...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab | CNN
CNN.com· 9 hours agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse...
FDA panel makes the call on much-anticipated Alzheimer's drug donanemab
USA TODAY via Yahoo News· 16 hours agoThe FDA is not compelled to follow the recommendation of the advisory committee of outside experts, but it often does so. A notable exception was when the advisory committee recommended the ...
...Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) and certain officers.
Peapack Gladstone Financial Corp Sells 143 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoPeapack Gladstone Financial Corp decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.8% during the fourth quarter, according to its most recent filing ...
BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal...
Benzinga· 3 days agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you